ReportsnReports – Epidemiology: HIV – Antiretrovirals prevail as patient population grows

259 views

Published on

The number of people living with HIV in the seven major markets (the US, Japan, France, Germany, Italy, Spain, and the UK) continues to increase and is believed to have reached 2.3 million by the end of 2009, 30% more than in 2001. Increases in diagnoses and improved prognosis will lead to an increase in the diagnosed prevalence of HIV, presenting a large market potential for therapeutic products.

Published in: Health & Medicine
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
259
On SlideShare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
2
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

ReportsnReports – Epidemiology: HIV – Antiretrovirals prevail as patient population grows

  1. 1. Epidemiology: HIV – Antiretrovirals prevail as patient population growsReportsnReports.com adds Datamonitor Market Research Report “ Epidemiology: HIV –Antiretrovirals prevail as patient population grows ’’ to its store.The number of people living with HIV in the seven major markets (the US, Japan, France,Germany, Italy, Spain, and the UK) continues to increase and is believed to have reached2.3 million by the end of 2009, 30% more than in 2001. Increases in diagnoses andimproved prognosis will lead to an increase in the diagnosed prevalence of HIV, presenting alarge market potential for therapeutic products.Features and benefitsGain insight into the market potential, including a robust 10-year epidemiological forecast ofdiagnosed HIV prevalent cases.Understand the key epidemiologic risk factors associated with HIV.HighlightsIn 2010, Datamonitor estimates that there were nearly 1.1 million diagnosed prevalentcases of HIV in the seven major markets (the US, Japan, France, Germany, Italy, Spain,and the UK). Between 2010 and 2021, Datamonitor forecasts that diagnosed HIV prevalentcases in the seven major markets will increase by 17%, to 1.3 million cases.In 2010, the US had the greatest number of prevalent diagnosed HIV ca of all the sevenmajor markets (819,500 cases), or 75% of all diagnosed prevalent cases in the seven majormarkets. By 2021, the number of prevalent diagnosed HIV cases in the US will increase to864,300.In the five major EU markets, there were 267,900 diagnosed prevalent HIV cases in 2010but will increase to 412,000 by 2021. Among the five EU markets, the UK had the greatestnumber of prevalent diagnosed HIV cases (75,800 cases) in 2010. Japan had about 12,000people living with diagnosed HIV in 2010 but this will increase to 18,800 by 2021.Your key questions answeredWhat is the number of people living with diagnosed HIV infection in the US, Japan, France,Germany, Italy, Spain, and the UK?How will the HIV patient population change over the next decade in the US, Japan, France,Germany, Italy, Spain, and the UK?What are the major risk factors of HIV that drive trends in HIV prevalence and how are theychanging?Table Of ContentsExecutive SummaryDisease burden overviewDatamonitor’s forecast of HIVDiagnosed prevalence
  2. 2. OVERVIEWCatalystSummaryDISEASE DEFINITION AND DIAGNOSIS CRITERIAHIV causes AIDSDiagnosis and testing of HIVClassification of HIV/AIDSGLOBAL VARIATION AND HISTORICAL TRENDSDisease burden overviewGlobal variationSub-Saharan Africa: the most affected regionEurope: increasing HIV diagnosis but declining AIDS casesNorth America and Western Europe: surging HIV epidemics in men who have sex with menHistorical trendsHIV in the seven major markets: stable diagnosis but increasing prevalenceDRIVERS OF HIV/AIDS EPIDEMIOLOGYThe US provides compelling evidence of the magnitude of HIV infection risk in men whohave sex with menInjection drug users and the epidemiology of HIVAfrican-Americans and sub-Saharan AfricansHemophiliacs and blood transfusion recipientsBlood transfusion, blood factor products, and occupational exposureCo-infection with other sexually transmitted infections or blood-borne virusesEPIDEMIOLOGIC FORECASTING OF HIVOverviewPopulation denominatorsAge-standardized prevalenceUSSources usedMethodsSources not usedJapanSources usedMethodsSources not usedFranceSources usedMethodsSources not usedGermanySources usedMethodsSources not usedItalySources used
  3. 3. MethodsSources not usedSpainSources usedMethodsSources not usedUKSources usedMethodsSources not usedCategorization and stratificationRisk groupsSexAgeDisease stageEPIDEMIOLOGIC RESULTSEstimated prevalent cases of HIV and future trendsSegmentation by ageSegmentation by risk groupSegmentation by sexSegmentation by disease stageDISCUSSIONUS: stabilizing epidemic but with the highest number of HIV patients in the industrializednationsFive major EU markets: resurgent HIV epidemicJapan: HIV epidemic yet to reach its peakStrengths and limits of Datamonitor’s epidemiologic projectionsBIBLIOGRAPHYJournal papersWebsitesAPPENDIXModule methodologyLatest Market Research Reports:Epidemiology: Osteopenia and Osteoporosis – On the rise as the aging population growsEpidemiology: Acute Coronary Syndrome – Now affecting primarily the oldest populationsWealth Management in France 2011Epidemiology: Stroke – Aging global population leads to more incident cases of strokeMerck & Co., Inc.: PharmaVitae Report
  4. 4. About Us:ReportsnReports is an online library of over 75,000 market research reports and in-depthmarket research studies & analysis of over 5000 micro markets. We provide 24/7 online andoffline support to our customers. Get in touch with us for your needs of market researchreports.Follow us on Twitter: http://twitter.com/marketsreportsOur Facebook Page: http://www.facebook.com/pages/ReportsnReports/191441427571689Contact:Mr. Priyank7557 Rambler road,Suite 727, Dallas, TX 75231Tel: +1-888-989-8004 EXT 106E-mail: sales@reportsandreports.comhttp://www.reportsnreports.comBlog: http://www.reportsnreportsblog.com

×